| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALRM | Common Stock | Options Exercise | $7.93K | +209 | +0.51% | $37.94 | 41.3K | Oct 1, 2021 | Direct | F1 |
| transaction | ALRM | Common Stock | Options Exercise | $30.2K | +1.08K | +2.62% | $27.90 | 42.4K | Oct 1, 2021 | Direct | F1 |
| transaction | ALRM | Common Stock | Options Exercise | $13.6K | +209 | +0.49% | $65.03 | 42.6K | Oct 1, 2021 | Direct | F1 |
| transaction | ALRM | Common Stock | Sale | -$118K | -1.5K | -3.52% | $78.72 | 41.1K | Oct 1, 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALRM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -209 | -2.33% | $0.00 | 8.75K | Oct 1, 2021 | Common Stock | 209 | $37.94 | Direct | F1, F3 |
| transaction | ALRM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -1.08K | -49.98% | $0.00 | 1.08K | Oct 1, 2021 | Common Stock | 1.08K | $27.90 | Direct | F1, F4 |
| transaction | ALRM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -209 | -3.24% | $0.00 | 6.25K | Oct 1, 2021 | Common Stock | 209 | $65.03 | Direct | F1, F5 |
| Id | Content |
|---|---|
| F1 | These exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.67 - $79.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F3 | The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each such date. |
| F4 | The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through November 1, 2021, subject to the Reporting Person's continued service with the Issuer through each such date. |
| F5 | The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through April 1, 2024, subject to the Reporting Person's continued service with the Issuer through each such date. |